Why is Astrazeneca Phar falling/rising?

As of 08-Jul, Astrazeneca Pharma India Ltd's stock price is currently at 9,140.00, reflecting an increase of 11.0 points or 0.12%. The stock has shown a positive trend recently, gaining 2.81% over the past week and outperforming its sector by 1.05%. However, it has experienced a decline of 6.35% over the last month. The stock has been on a consecutive gain streak for the last five days, but there is a notable decrease in investor participation, with delivery volume falling by 61.4% compared to the five-day average. Despite these mixed signals, the company has demonstrated strong financial performance, including an impressive net profit growth of 88.82% and a high return on equity (ROE) of 19.06%, which supports its positive outlook.
In the broader market context, Astrazeneca's short-term performance of +2.81% over the past week significantly outpaces the Sensex, which has only increased by 0.02% in the same period. This indicates that the stock is currently gaining traction relative to the overall market. However, the stock's long-term growth prospects are tempered by concerns regarding its high valuation metrics, such as a price-to-book value of 32.1 and a PEG ratio of 3.2, which suggest it may be trading at a premium compared to its peers. Additionally, the decline in institutional investor participation could signal caution among more sophisticated investors, potentially impacting future price movements.